Eliem Therapeutics (ELYM) Stock Chart & Stock Price History $1.88 -0.12 (-6.00%) As of 10/14/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Eliem Therapeutics Stock Price Performance The Eliem Therapeutics (ELYM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 65.44%, with a year-to-date return of 1.62%. In the past month, the stock has decreased 16.44%, reflecting recent market activity. As of the latest close, Eliem Therapeutics traded at $2.00 with a market cap of $59.50 million and volume of 600,177 shares. Receive ELYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+4.44%1 Month Performance-16.44%3 Month Performance+32.39%Year-To-Date Performance+1.62%1 Year Performance-65.44% ELYM Stock Chart for Wednesday, October, 15, 2025 ELYM Chart by TradingView Eliem Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$2.00$1.88-6.00%$2.04$1.881.60 million shs$55.93 million10/14/2025$1.80$2.00+11.11%$2.01$1.82600,177 shs$59.50 million10/13/2025$1.80$1.80$1.92$1.78550,659 shs$53.55 million10/10/2025$1.80$1.80$1.83$1.66597,102 shs$53.55 million10/09/2025$1.81$1.80-0.55%$1.83$1.66597,102 shs$53.55 million10/08/2025$1.81$1.81$2.06$1.80706,041 shs$53.85 million10/07/2025$1.98$1.81-8.59%$2.06$1.80706,041 shs$53.85 million10/06/2025$1.98$1.98$2.12$1.951.54 million shs$58.91 million10/03/2025$1.97$1.97$2.03$1.94346,019 shs$58.61 million10/02/2025$2.01$1.97-1.99%$2.03$1.94346,019 shs$58.61 million Get the Latest News and Ratings for ELYM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$1.99$2.01+1.01%$2.04$1.96391,176 shs$59.80 million09/30/2025$2.13$1.99-6.57%$2.21$1.97433,766 shs$59.21 million09/29/2025$2.13$2.13$2.21$2.02351,259 shs$63.37 million09/26/2025$2.25$2.10-6.67%$2.18$2.06337,856 shs$62.48 million09/25/2025$2.25$2.25$2.36$2.23283,283 shs$66.94 million09/24/2025$2.31$2.25-2.60%$2.36$2.23283,283 shs$66.94 million09/23/2025$2.31$2.31$2.44$2.25833,959 shs$68.73 million09/22/2025$2.31$2.31$2.44$2.25833,959 shs$68.73 million09/19/2025$2.12$2.24+5.66%$2.24$2.12382,367 shs$66.64 million09/18/2025$2.01$2.12+5.47%$2.19$2.02567,896 shs$63.07 million09/17/2025$2.04$2.01-1.47%$2.06$1.98422,939 shs$59.80 million09/16/2025$2.25$2.04-9.33%$2.29$2.03665,449 shs$60.69 million09/15/2025$2.25$2.25$2.45$2.24405,105 shs$66.94 million Related Companies Cellectis Stock Price Chart Cabaletta Bio Stock Price Chart Tonix Pharmaceuticals Stock Price Chart BioAge Labs Stock Price Chart SELLAS Life Sciences Group Stock Price Chart Aclaris Therapeutics Stock Price Chart Protalix BioTherapeutics Stock Price Chart Coherus Oncology Stock Price Chart Journey Medical Stock Price Chart GENFIT Stock Price Chart Receive ELYM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eliem Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELYM) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eliem Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eliem Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
